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Background: Successful implementation of malaria treatment policy depends on the prescription practices for
patients with malaria. This paper describes prescription patterns and assesses factors associated with co-prescription
of antibiotics and artemether-lumefantrine (AL) for patients presenting with fever in rural Tanzania.
Method: From June 2009 to September 2011, a cohort event monitoring program was conducted among all
patients treated at 8 selected health facilities in Ifakara and Rufiji Health and Demographic Surveillance System
(HDSS). It included all patients presenting with fever and prescribed with AL. Logistic regression was used to model
the predictors on the outcome variable which is co-prescription of AL and antibiotics on a single clinical visit.
Results: A cohort of 11,648 was recruited and followed up with 92% presenting with fever. Presumptive treatment
was used in 56% of patients treated with AL. On average 2.4 (1 – 7) drugs was prescribed per encounter, indicating
co-prescription of AL with other drugs. Children under five had higher odds of AL and antibiotics co-prescription
(OR = 0.63, 95% CI: 0.46 – 0.85) than those aged more than five years. Patients testing negative had higher odds
(OR = 2.22, 95% CI: 1.65 – 2.97) of AL and antibiotics co-prescription. Patients receiving treatment from dispensaries
had higher odds (OR = 1.45, 95% CI: 0.84 – 2.30) of AL and antibiotics co-prescription than those served in health
centres even though the deference was not statistically significant.
Conclusion: Regardless the fact that Malaria is declining but due to lack of laboratories and mRDT in most health
facilities in the rural areas, clinicians are still treating malaria presumptively. This leads them to prescribe more drugs
to treat all possibilities.
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Malaria remains a public health problem in Africa. It is
estimated to claim about 1 million deaths and over 400
million malaria cases worldwide each year, with 90%
of these deaths occurring in sub Saharan Africa [1]. In
Tanzania malaria has been reported as the leading cause
of death and account for 40% of all outpatient attendances
in health facilities [2]. Assessment of clinical symptoms is
the common method of diagnosing patient’s conditions in* Correspondence: mnjozi@ihi.or.tz
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reproduction in any medium, provided the orthe country, with most cases of fever being presumed to
be malaria. Few health facilities are equipped with basic la-
boratory services or use rapid diagnostic test to provide
confirmatory diagnoses of malaria; that has resulted into
misdiagnosis or over diagnosis of malaria. A study con-
ducted in Muhimbili National hospital showed 87% of
patients who received antimalarial treatment with a diag-
nosis of severe malaria did not have detectable parasitemia,
resulting in over-treatment of malaria and neglecting other
potentially life threatening conditions [2].
Fever has been used as a major clinical symptom for
malaria [3], Now reports show that malaria has been de-
clining [4], while fever remains a major complaint in
many outpatients clinical settings [5]. This high prevalenced. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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strengthen confirmation of malaria in order to target use
of antimalarial drugs to confirmed cases only. The
Tanzania National Guideline for diagnosis and treatment
of malaria states that, “a careful assessment of a patient
with suspected malaria is essential in order to differ-
entiate between uncomplicated and severe disease.
Eventually, laboratory investigations are done to com-
plement clinical diagnosis. In health care facilities with-
out laboratory services, diagnosis is based only on signs
and symptoms” [6]. Malaria treatment in Tanzania is
mainly based on clinical judgment in the majority of
health facilities, especially lower level facilities. Most of
the health facilities lack laboratory diagnostic capacity
for malaria and hence most of the reported malaria
cases are clinically diagnosed. According to NMCP,
up to early 2009, 83% of health facilities in Tanzania had
no laboratory diagnostic capacity for malaria. In addition,
there is a problem of inaccurate malaria microscopic
diagnosis and hence misdiagnosis of patients and over
use of ACT [7].
Microscopic examination of Giemsa-stained blood films
remains a cornerstone of malaria diagnosis throughout
Tanzania, but is only available at hospitals and some health
centers. Historically, more than 5,000 of the lowest-level fa-
cilities (dispensaries and some health centers) had no la-
boratory diagnostic capacity, leaving health care workers at
more than 90% of facilities to diagnose malaria on the basis
of clinical signs and symptoms alone. According to the re-
cent WHO guidelines, all suspected malaria cases should
be parasitological confirmed prior to treatment, including
children under five. NMCP’s policy has changed from pre-
sumptive treatment to confirmatory parasitological diagno-
sis. The NMCP objective is to increase the percentage of
laboratory-confirmed malaria cases in public health facil-
ities from a baseline of 20% to 80%. It is clear from numer-
ous assessments that the quality of malaria microscopy is
very poor at almost all levels of the health system. Phased
rollout of RDTs began in April 2009, starting in areas of
low/moderate transmission and expanded to areas of
stable/high transmission. Currently, laboratory confirm-
ation is happening in only 20% of the suspected cases and
there is no system for laboratory quality assurance and
quality control [8-11]. Over-diagnosis of malaria can lead
to inappropriate management of other causes of fever, un-
necessarily usage of antimalarials, increasing the burden of
malaria treatment cost, drug resistance and unsafe treat-
ment, or prolongation of illness and death [12-15]. Anti-
biotic resistance is increasingly becoming a public health
problem [13]. Improvement in antibiotics prescription will
reduce chances of bacterial resistance and minimize hos-
pital costs. In hospitals, currently the costs for antibiotics
accounts for more than 30% of hospital budgets, and
about one third to a half of all hospitalized patients receivean antibiotic [14]. It is necessary, therefore, to define and
assess the prescription patterns in order to address the
problem of irrational prescribing habits, and understand
types of drugs commonly co-prescribed with antimalarials
[15,16]. The World Health Organization (WHO) discour-
ages the use of large number of drugs per encounter and
irrational co-prescription of drugs with Artemisinin based
Combination Therapy (ACT) [9]. The assessment of drug
utilisation is important for both clinical and economic
reasons.
Several factors influences prescribing behaviour of cli-
nicians, therefore, to improve prescription behaviour, it
is necessary to understand predictors of those behaviours
[17,18]. This paper highlights the prescription patterns
and assesses the predictors of antibiotics co-prescription
with artemether-lumefantrine (AL), the first line recom-
mended antimalarial drug in Tanzania. The study was
conducted within 8 government health facilities found in
two Health and Demographic Surveillance Systems sites
that presented with fever or history of fever and treated
with AL.
Methods
The INDEPTH Effectiveness and Safety Studies of Anti-
malarial Drugs in Africa (INESS) is an exciting new plat-
form that aims to enable African researchers to carry
out large Phase IV trials [19]. INDEPTH Network Effect-
iveness and Safety Studies of Antimalarial Drugs in Africa
platform (INESS) operates in two HDSSs in Rufiji District,
Coast Region, and in Kilombero and Ulanga Districts,
around the town of Ifakara, Morogoro Region, Tanzania.
More explanations about the INESS platform is further
explained by Masanja [20].
Study area
The study was conducted in 8 selected health facilities
located in the Rufiji and Ifakara HDSS areas from May
2010 to December 2011. The Ifakara HDSS, situated
320 km south- west of Dar es Salaam, has been in oper-
ation since 1996. It covers part of Kilombero and Ulanga
districts with a total population of 99,000 people, served
by 14 health facilities [21]. Out of these 14 health facil-
ities in Kilombero & Ulanga districts only two health
centers have capacity of diagnosing malaria by using
microscopy, the remained facilities does not have that
capacity. They are dispensaries and do not have mi-
croscopy neither trained laboratory technicians. The
Rufiji HDSS is situated approximately 100 km south of
Dar es Salaam and has been operational since 1998. It
contains a population of approximately 85,000 people
served by a total of 16 health facilities [22]. In Rufiji
only 2 health centers and one dispensary can diagnose
malaria by using microscopy. 13 health facilities do not
have microscopy.
Table 1 Demographic characteristics and clinical
information of the study population
Variables Total (N = 11648)
Age, median (Inter quartile range) 6.4 (2 – 19)
Under fives, n (%) 5,005 (43)
Female, n (%) 6,361 (54.6)
Positive malaria n, (%) 4,013 (34.5)
Temperature, mean ± SD 37.7 ± 0.6°C
Taken medicine before going to health facility, n (%) 2,900 (25)
Average number of drugs prescribed, mean ± SD 2.4 ± 0.8
Proportion co-prescribed AL with antibiotics, n (%) 2,265 (19.5)
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The study design was a cohort event monitoring which
was observational, longitudinal and prospective. All pa-
tients prescribed AL from the 8 selected health facilities
within HDSS area were recruited. Patients were asked to
come to the health facility on day 3 and day 7 for clinical
evaluation and assessing their prognosis including if they
have experienced any of the side effects. They could
come at any day as well when they experienced any ad-
verse event or if they have any doubts. If patients did
not come at the health facility on scheduled days, they
were immediately followed up on the following day at
their respective households by a trained field worker,
and for some patients follow ups were conducted by
using phones. Phone was only used for those with mo-
bile phones and did not turn to the health facility on
scheduled days. Patients were declared lost to follow up
if three attempts have been made to trace him/her at
his/her households and five times by using mobile
phone. Information on demographic, complaining symp-
toms, laboratory investigations, past medical history,
past medical history, medication used and all events
were recorded at recruitment and during follow ups.
Study population
All patients attended 8 selected health facilities in Ifa-
kara and Rufiji HDSS areas that were prescribed with
artemether-lumefantrine for malaria treatment regard-
less of their demographic characteristics.
Ethical clearance
The INESS platform and its modules passed through and
were reviewed and approved by the Tanzanian National
Institutes of Medical Research and IHI’s Ethical Review
Boards with reference number IHI/IRB/No.A67-2009.
Data collection
At recruitment and after obtaining the informed consent
for participation in the study, data collection was done
using a standardized questionnaire developed in English
and translated into Kiswahili. Iinformation on demo-
graphic, complaining symptoms, laboratory investigations,
past medical history, present medical history, medication
used, history of drug reactions and all events were
collected. A trained clinician interviewed patients as
they come for treatment and once they were prescribed
with antimalarial a clinician filled in a clinical question-
naire. Follow up information was collected by trained
field workers using a standardized questionnaire on day 3
and 7.
Data management and analysis
All questionnaires used to collect information at recruit-
ment and at follow up were taken for manual editing,validation and data entry which was done using the
Epidata 3.1 [23]. Data entry was done by Ifakara Data man-
agement unit and double entry was done to minimize data
entry errors. Quality of data was done by re-interviewing
the patients by the field supervisor. Data cleaning and ana-
lysis was done using Stata 11 [24]. Descriptive statistics
was used in reporting the major results and findings
on the prescription patterns and estimation of drugs per
encounter. Logistic regression was used in the assessment
of predictors of antibiotics co-prescriptions. Clustering
was done for health facility, assuming that individuals
attending the same facility are more homogeneous. Stat-
istical significance was based on the p-value being less
than 0.05.
Results
Demographic and clinical information
A total of 11,648 patients who were prescribed with AL
were recruited from eight government health facilities in
Ifakara HDSS and Rufiji HDSS. More than half (55%)
were female, median age was 6.4 years (Inter Quartile
Range: 2 – 19) and a quarter of the patients had used
medicine before getting to the health facility (see Table 1).
A total of 5076 patients were tested for malaria, of them
3,953 were BS tested and 1,410 were malaria rapid diag-
nostic test (mRDT) tested with some had both. About
80% of those tested with Microscope were found positive
with 67% of those tested with mRDT were found positive
while others were treated based on their presenting clin-
ical symptoms. See Figure 1.
On average each patient presented 2.5 symptoms/
events at recruitment. About 92% of patients presented
fever as a symptom at enrolment with other common
symptoms being cough, vomiting, joint pain, abdominal
pain and body weakness. See Figure 2.
All patients included in the cohort took AL, and the
average number of drugs prescribed was 2.4 drugs per
patient on a single clinical visit with some receiving as
many as seven drugs. Common drugs co-prescribed with
AL were a class of analgesics with 51% of patients and
Figure 1 Presentation of diagnosis and drug prescriptions.
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counters. Other classes of drugs were co-prescribed with
AL in less than 5% of the patients.
Analysis of AL and antibiotics co-prescription
From the univariate and multivariate analysis children
aged five years and more had 0.37 lesser odds to have
been co-prescribed with antibiotics as compared to older
patients. Patients testing negative had higher odds of
2.12 being prescribed with AL and antibiotics as than
those testing positive with malaria. There was no signifi-
cant difference between not tested patients and those
tested positive regarding antibiotics co-prescription. Pa-
tients diagnosed and treated at dispensaries were 1.45
higher odds to be co-prescribed with AL and antibiotics,
but the difference was not significant. Gender of pa-
tients, temperature range and season of diagnosis had
no influence on antibiotics co-prescription. More infor-
mation on univariate and multivariate analysis results on
Table 2.
Discussion
Presumptive treatment is still practiced in rural areas of
















Figure 2 Proportion of common presenting symptoms.attending to government health facilities were treated
with AL without parasitological confirmation. This might
be due to the WHO’s integrated management of child-
hood illness (IMCI) strategy [16]. The IMCI strategy, al-
lows children under five years to be presumptively treated
on malaria [11]. Regardless of the cost effectiveness of
IMCI as explained in [25], there is a need to revise strat-
egies for malaria treatment for children under five for im-
proved malaria treatment outcomes and observation of
other fever caused diseases. As Okebe and colleagues and
Winskill et al. [26,27] suggested, children aged 5–15 have
higher odds of having malaria than those under five, and
this might be due to more focus on under five and causes
disease burden to shift to higher age. The Tanzanian Na-
tional Guidelines for diagnosis and treatment of malaria
(2006) stress the use of parasitological confirmation to
supplement on clinical symptoms of malaria, and allows
for presumptive treatment only when facilities have no la-
boratory or malaria rapid diagnostic test [6].
Findings from this study shows that presumptive treat-
ment was done for all age groups; under five and those
above 5 years. Similar results of presumptive treatment
for malaria patients above 5 years was fund in study
done in Kenya [16]. Presumptive treatment is commonly
due to lack of laboratory expertise and stock-out of
mRDT. The practice is commonly done in high trans-
mission areas like the study area [28]. This study shows
20% of patients who were treated with AL were negative,
this might be due to poor training of laboratory techni-
cians and poor slides management which leads to mis-
trust of results and hence clinicians dispensing AL
basing on clinical symptoms [27]. Also reported that in
some cases clinicians tends to use “mind lines” instead
of guidelines when it comes to malaria treatment [29].
The mean number of drugs prescribed was 2.4 drugs per
patient per encounter, which is above the WHO guidelines
on rational use of drugs with reference values of (1.6-1.8)
drugs per encounter [30]. Since all patients received AL
then there was a mean of 1.4 drugs co-prescribed with AL
Table 2 Univariate and multivariate predictors for AL co-prescribed with antibiotics
Variable
Univariate Multivariate
Odds ratio 95% CI P - value Odds ratio 95% CI P - value
Age group
< 5 years Referent
5 + years 0.63 0.47 - 0.84 0.007 0.63 0.46 - 0.85 0.009
Sex
Male Referent
Female 1.02 0.91 - 1.145 0.674 1.09 0.98 - 1.20 0.087
Temperature range
< 38.5°C Referent
≥ 38.5°C 0.91 0.71 - 1.16 0.381 0.85 0.64 - 1.12 0.204
Season
Low transmission Referent
High transmission 1.16 0.72 - 1.87 0.49 1.20 0.71 - 0.05 0.441
Facility type
Health centre Referent
Dispensary 1.45 0.84 - 2.50 0.156 1.39 0.84 - 2.30 0.164
Malaria test results
Positive Referent
Negative 2.12 1.34 - 3.34 0.006 2.21 1.65 - 2.97 0.001
Not tested 1.14 0.82 - 1.57 0.383 1.03 0.69 - 1.54 0.859
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children, and number of drugs per encounter seems lower
as compared to 3.2 per encounter reported for children
in Uganda [31]. Patient receiving the least number of
drugs were the one who received AL alone and max-
imum number of drugs prescribed was 7 drugs per en-
counter. The number of drugs prescribed was relatively
high as compared to 2.1 per person per encounter re-
ported in previous study in Kilombero District (an area
included in this study) [32].
Analgesics were commonly prescribed class of drugs
as more than 50% of patients prescribed AL were co-
prescribed it with Analgesics. This is a common practice
to clinicians and reported in other countries such as
Sudan [33] and Yemen [34]. History of fever or present-
ing fever suggested the use of these Analgesics [35], even
though the mean temperature did not suggest that as per
WHO guidelines [12]. There is a good reason for prescrib-
ing analgesics with AL for patients presenting with fever,
as they might need medicines to manage fever while con-
tinuing with antimalarial treatment.
The study indicates that antibiotics were co-prescribed
for 20% of encounters which is less compared to 30.8%
observed in Ghana [36]. Antibiotics are associated with
some adverse reactions [36] and hence need to be used
with great care to reduce those reactions. Other classes
of drugs were co-prescribed with AL but in lower ratesof less that 5% includes micronutrients supplements,
antihelminths, antihistamines and antipsychotics.
Furthermore this study assessed the predictors of anti-
biotics co-prescription. Predictors found to be associated
with the risk of being co-prescribed of other drugs with
AL were age group and type of diagnosis (positive, nega-
tive and not tested). Children aged less than five years
were more likely to be co-prescribed with antibiotics than
those aged 5 years and more (Table 2). Similar findings
were reported by Torvi et al. in [17]. This might be due to
paediatrics being in high risk to suffer from recurrent in-
fections of other systems such as the respiratory tract and
gastrointestinal system as seen from Figure 1 that cough
was a major symptom after fever and headache [37].
Patients with fever who had negative results on mal-
aria, due to lack of laboratory services, clinicians tend to
deal with all possibilities by giving antimalarial if fever
was due to malaria and antibiotics if fever was caused by
bacterial infection or analgesics for fever itself. A similar
observation was done in Zanzibar as those with clinical
diagnosis were more likely to be co-prescribed with anti-
biotics as compared to those with malaria rapid diagnosis
tests (mRDT). Those who were not tested were presump-
tively treated and IMCI guidelines were used for children
under five years [38]. For patients positive tested with mal-
aria co prescription was given when deemed necessary as
clinicians were almost certain of patient’s problem. For
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ical symptoms and clinicians used their knowledge at best
to assess the need for the co-prescription [38].
Conclusion
Fever is still the main complain regardless malaria de-
cline. Presumptive treatment is still practised. When a
child is having fever and tested malaria negative clini-
cians tends to give more drugs including atimalarial to
cure for all possibilities.
Recommendations
More training and supervision of clinicians’ prescription
pattern especially to children to avoid concomitant use
of antibiotics.
Authorities should make sure that facilities are equipped
with mRDT or laboratory for better malaria diagnosis and
minimise the un-necessary prescription of antibiotics.
Limitations
Study was conducted for outpatients who were treated
with artemether-lumefatrine and can never be general-
ized for in-patients treated with any antimalarial drug or
outpatients not treated with artemether-lumefatrine. The
study was non-interventional and did not assess whether
prescription was appropriate for reported symptom and
according to diagnosis.
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